Summary Information:
Pulse Biosciences Inc Common Stock (DE)
NASDAQ:PLSE


email
admin@troach.net
Our Main Pages
Stocks.TRoach.Net
TRoach.Org
TRoach.Net

NOTE: This page is for evaluation of a JFF Project.
This page is NOT updated on a regular basis.
Information on this page should NOT be used for investment purposes.


Pulse Biosciences Inc Common Stock (DE)
Exchange: NASDAQ
Symbol: PLSE
SEC CIK: 0001625101
Phone: 510-906-4600
3957 POINT EDEN WAY
HAYWARD CA 94545

CEO:
Price when page updated: 9.24 Date: 2023-12-01
Company Website:
www.pulsebiosciences.com

_Description: Pulse Biosciences is a novel bioelectric medicine company committed to health innovation that has the potential to improve the quality of life for patients. The CellFX® System is the first commercial product to harness the distinctive advantages of the Company's proprietary Nano-Pulse Stimulation™ (NPS™) technology, such as the ability to non-thermally clear cells while sparing non-cellular tissue, to treat a variety of applications for which an optimal solution remains unfulfilled. Nano-Pulse Stimulation technology delivers nano-second pulses of electrical energy. The initial commercial use of the CellFX System is to address a range of dermatologic conditions that share high demand among patients and practitioners for improved dermatologic outcomes. Designed as a multi-application platform, the CellFX System offers customer value with a utilization-based revenue model.

IPO YEAR:
2016
Sector:
Health Care
Industry:
Medical/Dental Instruments
ADRTSO:

MarketCap:
508121340.00
Beta:
1.289480922563921
52 Week High:
45.82
52 Week Low:
14.59
52 Week Change:
-0.3276481149012568
Short Interest:

Short Date:

Shares Outstanding:
29631283
Dividend Rate:
0
Dividend Yield:
3.71%
ExDividend Date:

Latest EPS:

Latest EPS Date:
31 Oct 2022
Float:
0
return on Equity:
-14.60%
Consensus EPS:

Number Of Estimates:

EPS Surprise Dollar:

Eps Surprise Percent:

EBITDA:
$57.759M
ttmEPS:
0
Revenue:
$570.743M
Gross Profit:

Cash:

Debt:

Institution Percent:
-
Revenue Percent:

Revenue Per Employee:

Insider Percent:
0.10%
Return on Assets:
2.50%
Return on Capital:

Profit Margin:
8.30%
Price to Sales:
7.32
Price To Book:
-
Short Ratio:
3.87
PE Ratio:
0
Employees:
95
1Y Guesstimate
N/A:N/A:N/A




__The following are links to various summary and news pages for
__Pulse Biosciences Inc Common Stock (DE) [ PLSE ].

__Note: Some Links might not have information for the company.


finance.Yahoo.com money.CNN.com NASDAQ research
WalletInvestor.com WSJ.com MarketBeat.com
finviz.com WallMine.com TheGlobeandMail.com
stock1010.com
NASDAQ - General Info SEC Insider Report Ownership Summary
Dividend History insiderbuyingselling.com
Facebook search Twitter search LinkedIn search
PRnewsWire.Com Google Forecast
tdameritrade.com BarChart.com
SeekingAlpha.com Markets.FT.com stocktwits.com
FinTel.io Ldmicro.com bloomberg.com
MarketWatch.com Reuters.com businessinsider.com
fool.com barrons.com zacks.com
GuruFocus.com Investing.com tipranks.com
thestreet.com nytimes.com earningswhispers.com
marketchameleon.com sunshineavenue.com stockinvest.us
stockanalysis.com stockconsultant.com ycharts.com
financialcontent.com docoh.com foxbusiness.com
cnbc.com investorsobserver.com tradingview.com
investopedia.com tmxmoney.com invest.cnyes.com
ask.com bing.com brave.com
duckduckgo.com ecosia.org excite.com
exalead.com gibiru.com hotbot.com
www.info.com infospace.com lycos.com
lukol.com metacrawler.com mojeek.com
becovi.com searx.thegpm.org search.com
swisscows.com webcrawler.com yahoo.com
yandex.com yep.com you.com




INDEX




Page design by: TRoach
Page Last Updated: 2023-12-01